Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Emmanuel Musabeyezu"'
Autor:
Janvier Serumondo, Michael J. Penkunas, Julienne Niyikora, Alida Ngwije, Athanase Kiromera, Emmanuel Musabeyezu, Justine Umutesi, Sabine Umuraza, Gentille Musengimana, Sabin Nsanzimana
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Direct-acting antivirals (DAAs) are increasingly accessible to patients with hepatitis C (HCV) worldwide and are being introduced through national health systems in sub-Saharan Africa. DAAs are highly efficacious when tested in co
Externí odkaz:
https://doaj.org/article/e8dc47cd2974431ca8331e8dafb4c520
Autor:
Philip Grant, Fabienne Shumbusho, Jennifer Ilo Van Nuil, Fredrick Kateera, Joia Mukherjee, Jules Kabahizi, Fabien Ntaganda, Sabin Nsanzimana, Aimable Mbituyumuremyi, Makuza Jean Damascene, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Cyprien Ntirenganya, Neil Gupta
Publikováno v:
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy,
Externí odkaz:
https://doaj.org/article/f713c5424c644477a299283a32ddc6cd
Autor:
Neil Gupta, Jules Kabahizi, Constance Mukabatsinda, Timothy David Walker, Emmanuel Musabeyezu, Athanase Kiromera, Jennifer Ilo Van Nuil, Kevin Steiner, Joia Mukherjee, Sabin Nsanzimana, Aimable Mbituyumuremyi
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174148 (2017)
BACKGROUND:Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This
Externí odkaz:
https://doaj.org/article/1df48508454142b0a4add4793c486eec
Autor:
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:1036-1048
Hepatocellular carcinoma is a leading public health concern in sub-Saharan Africa, and it is most prevalent in young adults (median 45 years [IQR 35-57]). Overall, outcomes are poor, with a median survival of 2·5 months after presentation. Major ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47311e2643dae8c5bbadc3642d7d7cf
https://doi.org/10.1016/s2468-1253(22)00041-3
https://doi.org/10.1016/s2468-1253(22)00041-3
Autor:
Neil Gupta, Jules Kabahizi, Emmanuel Musabeyezu, Alain Mukuralinda, Claude Mambo Muvunyi, Sabin Nsanzimana, Fabienne Shumbusho, Constance Mukabatsinda, Aimable Mbituyumuremi, Jennifer Ilo Van Nuil, Fredrick Kateera, Joia Mukerjee
Publikováno v:
BASE-Bielefeld Academic Search Engine
An estimated 71 million people live with hepatitis C virus (HCV) and without an effective vaccination, control efforts depend entirely on prevention, early diagnosis, and treatment with direct acting antiviral medication. The experiences of accessing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9dab317d35055945e3cb2c94b23056
https://doi.org/10.1080/17441692.2020.1801787
https://doi.org/10.1080/17441692.2020.1801787
Autor:
Fabienne Shumbusho, Sabin Nsanzimana, Joia S. Mukherjee, Fredrick Kateera, Aimable Mbituyumuremyi, Claude Mambo Muvunyi, Emmanuel Musabeyezu, Constance Mukabatsinda, Neil Gupta, Cyprien Ntirenganya, Philip M. Grant, Jules Kabahizi, Makuza Jean Damascene, Fabien Ntaganda, Jennifer Ilo Van Nuil
Publikováno v:
Hepatology Communications
BASE-Bielefeld Academic Search Engine
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
BASE-Bielefeld Academic Search Engine
Hepatology Communications, Vol 4, Iss 4, Pp 569-576 (2020)
Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24d7555772938d6b7472215f366478b
http://europepmc.org/articles/PMC7109339
http://europepmc.org/articles/PMC7109339
Autor:
Neil Gupta, Linda Manirambona, Fabienne Shumbusho, Jules Kabihizi, Anthere Murangwa, Janvier Serumondo, Jean Damascene Makuza, Sabin Nsanzimana, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Gregory Camus, Philip M Grant, Fredrick Kateera
Publikováno v:
The lancet. Gastroenterologyhepatology. 7(6)
Hepatitis C virus (HCV) genotype 4 non-a/d subtypes, which frequently have NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These subtypes, particularly genotype 4r, have been associated with higher rates of failu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c770cdda6b8d7e4be1d607be73586286
https://pubmed.ncbi.nlm.nih.gov/35248214
https://pubmed.ncbi.nlm.nih.gov/35248214
Autor:
Sabin Nsanzaimana, Jean Damascene Makuza, Emmanuel Musabeyezu, Philip M. Grant, Claude Mambo Muvunyi, Anne F. Liu, Janvier Serumondo, Neil Gupta, Fredrick Kateera, Fabienne Shumbusho, Jules Kabahizi
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(4)
In sub-Saharan Africa, there exist distinct HCV genotype (GT) subtypes harbouring resistance-associated substitutions to commonly used non-structural protein 5A (NS5A) inhibitor-based direct-acting antiviral (DAA) regimens. In particular, GT4r subtyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ffadfddba11f5e80da654eea5d3ffc
https://pubmed.ncbi.nlm.nih.gov/33421247
https://pubmed.ncbi.nlm.nih.gov/33421247
Autor:
Sabine Umuraza, Athanase Kiromera, Gentille Musengimana, Alida Ngwije, Emmanuel Musabeyezu, julienne niyikora, Janvier Serumondo, Michael J Penkunas, Justine Umutesi, Sabin Nsanzimana
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Public Health
BMC Public Health
Background Direct-acting antivirals (DAAs) are increasingly accessible to patients with hepatitis C (HCV) worldwide and are being introduced through national health systems in sub-Saharan Africa. DAAs are highly efficacious when tested in controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a59dfeb7fc9c6106ab19b6830dd5e83
https://doi.org/10.1186/s12889-020-09000-0
https://doi.org/10.1186/s12889-020-09000-0
Autor:
Sabin Nsanzimana, Janvier Serumondo, Fabienne Shumbusho, Neil Gupta, Fredrick Kateera, Emmanuel Musabeyezu, Grace Umutesi, Alida Ngwije, Jules Kabahizi
Publikováno v:
Journal of Hepatology. 70:1043-1045
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d2ac771154c81b9b5b1b58e0ddfc68
https://doi.org/10.1016/j.jhep.2019.03.011
https://doi.org/10.1016/j.jhep.2019.03.011